Monoclonal Antibody Plus Cyclophosphamide in Treating Patients With Metastatic Cancer

Status unconfirmed · Phase 1/Phase 2

Conditions studied: Unspecified Adult Solid Tumor, Protocol Specific

In brief

RATIONALE: Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. PURPOSE: Phase I/II trial to study the effectiveness of monoclonal antibody and cyclophosphamide in treating patients with metastatic cancer.

Key facts

Study ID

NCT00002482

Run by

St. Vincent Medical Center - Los Angeles

Starts

1991-06-01

Last updated by the study team

2013-11-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• St. Vincent Medical Center - Los Angeles — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.